tiprankstipranks
Trending News
More News >
Valerio Therapeutics (FR:ALVIO)
:ALVIO
Advertisement

Valerio Therapeutics (ALVIO) Price & Analysis

Compare
0 Followers

ALVIO Stock Chart & Stats


ALVIO FAQ

What was Valerio Therapeutics’s price range in the past 12 months?
Valerio Therapeutics lowest stock price was €0.04 and its highest was €0.14 in the past 12 months.
    What is Valerio Therapeutics’s market cap?
    Valerio Therapeutics’s market cap is €20.14M.
      When is Valerio Therapeutics’s upcoming earnings report date?
      Valerio Therapeutics’s upcoming earnings report date is Jul 24, 2025 which is 78 days ago.
        How were Valerio Therapeutics’s earnings last quarter?
        Currently, no data Available
        Is Valerio Therapeutics overvalued?
        According to Wall Street analysts Valerio Therapeutics’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Valerio Therapeutics pay dividends?
          Valerio Therapeutics does not currently pay dividends.
          What is Valerio Therapeutics’s EPS estimate?
          Valerio Therapeutics’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Valerio Therapeutics have?
          Valerio Therapeutics has 350,507,930 shares outstanding.
            What happened to Valerio Therapeutics’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Valerio Therapeutics?
            Currently, no hedge funds are holding shares in FR:ALVIO

            Company Description

            Valerio Therapeutics

            Valerio Therapeutics (ALVIO) is a biotechnology company focused on developing innovative therapies for patients with unmet medical needs, particularly in the fields of oncology and chronic diseases. The company leverages advanced research and development techniques to create targeted treatments that aim to improve patient outcomes and quality of life. Valerio Therapeutics is committed to bringing cutting-edge solutions to the market, with a portfolio that includes proprietary drug candidates and collaboration with healthcare professionals to facilitate clinical trials.

            Valerio Therapeutics (ALVIO) Earnings & Revenues

            Similar Stocks
            Company
            Price & Change
            Follow
            Hybrigenics SA Class A
            TME Pharma N.V.
            Biophytis SA
            Theranexus SA
            NFL Biosciences SA
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis